Cadre Holdings, Inc. (CDRE) stock

CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 15/3015% above fair value

$33.42+0.34 (+1.03%)

Close on Nov 13, 2026Market cap $1.43BP/E 36.7Yield 1.14%

Cadre EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Cadre's EV/EBITDA was 19.5× on Nov 11, 2026, against 20.1× a year earlier. Over the last 5 years it ranged from 12.5× to 42.7×, with a median of 19.4×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	19.5×	+0.2
2025	Dec 31, 2025	19.3×	−2.4
2024	Dec 31, 2024	21.7×	+3.6
2023	Dec 29, 2023	18.1×	−13.5
2022	Dec 30, 2022	31.6×	+17.5
2021	Dec 31, 2021	14.0×	–

Where these numbers come from

Parsed from the XBRL in Cadre's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CDRE.

Compare: CDRE vs MSA · CDRE vs LAKE · CDRE vs UFPT · CDRE vs ENOV · CDRE vs INGN

Revenue growth18.3% · median 6.5%

Gross margin42.0% · median 44.1%

Operating margin10.7% · median -4.1%

Net margin5.6% · median -9.3%

Company	Revenue	Growth
ENOV	$2.31B	+3.3%
MSA	$1.95B	+6.5%
CDRE	$732.66M	+18.3%
UFPT	$649.52M	+8.6%
INGN	$379.32M	+13.7%
LAKE	$190.96M	-0.3%

Company

Next earnings (est.): Mar 9, 2027, during market hours
Exchange: NYSE
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Fiscal year ends: December 31
Employees: 2,533
Held by institutions: 78.1%
Auditor: KPMG LLP
SEC CIK: 1860543

Advertisement
300 × 250

See a number that looks wrong?